Lexeo Therapeutics, Inc. Common Stock (LXEO) News

Latest headlines that mention LXEO, newest first · each headline opens the original publisher

LXEO quote

Last price: $2.92
Day change: -2.50%
Next earnings: 2026-11-04

Quote & chart Expected move Insider trading IV rank history

LXEO headlines

latest coverage

Seeking Alpha News 17h ago

Lexeo Therapeutics, Inc. (LXEO) Discusses Clinical Assessment and Unmet Need in PKP2 Arrhythmogenic Cardiomyopathy Transcript

General T2LXEO

Investing.com 2d ago

Lexeo at Chardan healthcare conference: pipeline advances, cash runway

General T3LXEO

Investing.com 22d ago

Lexeo Therapeutics completes acquisition of Mantle Therapeutics

M&A T3LXEO

Investing.com 29d ago

Lexeo gains access to Apertura’s gene therapy capsid

General T3LXEO

Seeking Alpha News 1mo ago

Lexeo Therapeutics, Inc. (LXEO) M&A Call Transcript

General T2LXEO

Seeking Alpha News 1mo ago

Lexeo Therapeutics, Inc. (LXEO) Mantle Therapeutics Inc. - M&A Call - Slideshow

General T2LXEO

Investing.com 1mo ago

Raymond James reiterates Strong Buy on Lexeo stock after acquisition

M&A T3LXEO RJF

Seeking Alpha 2mo ago

Lexeo Therapeutics GAAP EPS of -$0.30 misses by $0.01

Earnings T2LXEO

Yahoo Finance 3mo ago

What Makes Lexeo Therapeutics (LXEO) One of The Best Stocks Under $10 That Could Triple

General T2LXEO

Yahoo Finance 3mo ago

Is Lexeo Therapeutics, Inc. (LXEO) Stock Still a Gene Therapy Opportunity After Analyst Valuation Update?

General T2LXEO

Investing.com 3mo ago

Form 144 Lexeo Therapeutics For: 1 July

General T3LXEO

Seeking Alpha News 3mo ago

Lexeo Therapeutics, Inc. (LXEO) Discusses Phase III Program Design and Durable Cardiac Improvements in Friedreich's Ataxia Transcript

General T2LXEO

Seeking Alpha News 4mo ago

Lexeo Therapeutics's LX2006 Has A Viable Regulatory Pathway And Timeline

General T2LXEO

Seeking Alpha News 4mo ago

Lexeo Therapeutics, Inc. (LXEO) Shareholder/Analyst Call Transcript

General T2LXEO

Seeking Alpha News 4mo ago

Lexeo Therapeutics, Inc. (LXEO) Shareholder/Analyst Call - Slideshow

General T2LXEO

Investing.com 4mo ago

Lexeo finalizes pivotal trial design for gene therapy LX2006

General T3LXEO

Seeking Alpha 5mo ago

Lexeo Therapeutics GAAP EPS of -$0.25

Earnings T2LXEO

LXEO news alerts

Get an alert by email or push when a new headline mentions LXEO.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.